METHYL 6-AMINO-6-DEOXY-GALACTOPYRANOSIDE
|
|
- CAS-Nr.
- 5155-47-5
- Englisch Name:
- METHYL 6-AMINO-6-DEOXY-GALACTOPYRANOSIDE
- Synonyma:
- METHYL 6-AMINO-DEOXY-GALACTOYRANOSIDE;METHYL 6-AMINO-6-DEXOY-D-GLUCOPYRANOSIDE;METHYL 6-AMINO-6-DEOXY-GALACTOPYRANOSIDE;2-(aminomethyl)-6-methoxyoxane-3,4,5-triol;Methyl-6-amino-6-deoxy-a-D-Glucopyranoside;Methyl 6-amino-6-deoxy-α-D-glucopyranoside;α-D-Glucopyranoside, methyl 6-amino-6-deoxy-;1-O-Methyl-6-deoxy-6-amino-α-D-glucopyranose;Methyl 6-amino-6-deoxy-alpha-D-glucopyranoside;Methyl 6-?Amino-?6-?deoxy-α-?D-?glucopyranoside
- CBNumber:
- CB0210940
- Summenformel:
- C7H15NO5
- Molgewicht:
- 193.2
- MOL-Datei:
- 5155-47-5.mol
|
METHYL 6-AMINO-6-DEOXY-GALACTOPYRANOSIDE Eigenschaften
- Siedepunkt:
- 369.5±42.0 °C(Predicted)
- Dichte
- 1.39±0.1 g/cm3(Predicted)
- storage temp.
- 2-8°C
- Aggregatzustand
- Off-white to yellow syrup/ oil
- pka
- 12.94±0.70(Predicted)
Sicherheit
- Risiko- und Sicherheitserklärung
- Gefahreninformationscode (GHS)
Bildanzeige (GHS) |
|
Alarmwort |
Warnung |
Gefahrenhinweise |
Code |
Gefahrenhinweise |
Gefahrenklasse |
Abteilung |
Alarmwort |
Symbol |
P-Code |
H315 |
Verursacht Hautreizungen. |
Hautreizung |
Kategorie 2 |
Warnung |
src="/GHS07.jpg" width="20" height="20" /> |
P264, P280, P302+P352, P321,P332+P313, P362 |
H319 |
Verursacht schwere Augenreizung. |
Schwere Augenreizung |
Kategorie 2 |
Warnung |
src="/GHS07.jpg" width="20" height="20" /> |
P264, P280, P305+P351+P338,P337+P313P |
H335 |
Kann die Atemwege reizen. |
Spezifische Zielorgan-Toxizität (einmalige Exposition) |
Kategorie 3 (Atemwegsreizung) |
Warnung |
src="/GHS07.jpg" width="20" height="20" /> |
|
|
Sicherheit |
P210 |
Von Hitze, heißen Oberflächen, Funken, offenen Flammen und anderen Zündquellenarten fernhalten. Nicht rauchen. |
|
METHYL 6-AMINO-6-DEOXY-GALACTOPYRANOSIDE Chemische Eigenschaften,Einsatz,Produktion Methoden
Verwenden
Methyl 6-?Amino-?6-?deoxy-α-?D-?glucopyranoside is an intermediate in synthesizing Ranimustine (R120030), a nitrosourea alkylating agent approved in Japan for the treatment of chronic myelogenous leukemia and polycythemia vera. It can be used in biological study of synthesis of anti-EGFR antibody-drug conjugates. It can also be used in therapeutic use and biological study of BCMA (B-Cell Maturation Antigen) antigen binding proteins.
METHYL 6-AMINO-6-DEOXY-GALACTOPYRANOSIDE Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
METHYL 6-AMINO-6-DEOXY-GALACTOPYRANOSIDE Anbieter Lieferant Produzent Hersteller Vertrieb Händler.
Global( 29)Lieferanten
5155-47-5()Verwandte Suche:
- Methyl 6-amino-6-deoxy-alpha-D-glucopyranoside
- METHYL 6-AMINO-DEOXY-GALACTOYRANOSIDE
- Methyl-6-amino-6-deoxy-a-D-Glucopyranoside
- 1-O-Methyl-6-deoxy-6-amino-α-D-glucopyranose
- Methyl 6-amino-6-deoxy-α-D-glucopyranoside
- (2R,3S,4S,5R,6S)-2-(aMinoMethyl)-6-Methoxytetrahydro-2H-pyran-3,4,5-triol
- METHYL 6-AMINO-6-DEOXY-GALACTOPYRANOSIDE
- METHYL 6-AMINO-6-DEXOY-D-GLUCOPYRANOSIDE
- 2-(aminomethyl)-6-methoxyoxane-3,4,5-triol
- α-D-Glucopyranoside, methyl 6-amino-6-deoxy-
- Methyl 6-?Amino-?6-?deoxy-α-?D-?glucopyranoside
- (2R,3S,4S,5R,6S)-2-(aminomethyl)-6-methoxyoxane-3,4,5-triol
- 5155-47-5